# Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature

> **NCT01497938** · PHASE3 · COMPLETED · sponsor: **Medtronic MiniMed, Inc.** · enrollment: 247 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature
- **DEVICE:** Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump

## Key facts

- **NCT ID:** NCT01497938
- **Lead sponsor:** Medtronic MiniMed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2014-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01497938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01497938, "Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT01497938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*